Status:
RECRUITING
Mucosal IgE to Improve Diagnosis of Food Allergy and Food Hypersensitivity
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Food Allergy
Food Hypersensitivity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parame...
Detailed Description
Food intolerances (FI) show an increasing prevalence and represent a particular challenge in clinical practice. The symptoms of a predominantly gastrointestinally mediated food allergy (FA) are simila...
Eligibility Criteria
Inclusion
- informed consent
- patients with suspected food allergy or hypersensitivity
- healthy controls with indications for endoscopic diagnostics, e.g. tumour history within the family, exclusion of gastritis
Exclusion
- pregnant person
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT05259826
Start Date
February 1 2022
End Date
January 31 2025
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg
Erlangen, Germany, 91052